1. Coronary vasomotor dysfunction is associated with worse outcomes in patients with inflammatory disease. (25th November 2020) Authors: Weber, B; Brown, J.M; Divakaran, S; Stevens, E; Hainer, J; Bibbo, C; Taqueti, V; Blankstein, R; Dorbala, S; Massarotti, E; Costenbader, K; Liao, K; Dicarli, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P2769Nonalcoholic fatty liver disease: a marker of coronary microvascular dysfunction. (28th August 2018) Authors: Vita, T S; Murphy, D; Osborne, M; Bajaj, N; Abhishek, K; Jacob, S; Diaz, A; Nodoushani, A; Bravo, P; Bibbo, C; Steigner, M; Taqueti, V; Blankstein, R; Di Carli, M; Dorbala, S Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗